Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report
This paper discussed the International Myeloma Working Group (IMWG) recommendations for the use of Mass Spectrometry in plasma disorders. Overall, this article highlights the significance of mass spectrometry in the diagnosis and monitoring of these conditions, including the evaluation of monoclonal proteins in multiple myeloma and related disorders.